These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2476703)

  • 1. [Prenatal screening for Down's syndrome by measuring the AFP concentration in the maternal serum].
    Veress L; Szabó M; Polgár K; Takács L; Papp Z
    Orv Hetil; 1988 Jul; 129(31):1677. PubMed ID: 2476703
    [No Abstract]   [Full Text] [Related]  

  • 2. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alpha-fetoprotein and trisomy 21].
    Guibaud S; Boisson C; Simplot A; Thoulon JM; Favier JP; Guibaud P; Robert JM
    J Genet Hum; 1988 Aug; 36(4):347-51. PubMed ID: 2464665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic counseling and prenatal diagnosis in Down's syndrome].
    Papp Z
    Orv Hetil; 1974 May; 115(19):1103-6. PubMed ID: 4274931
    [No Abstract]   [Full Text] [Related]  

  • 5. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
    Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
    Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down's syndrome: current screening techniques.
    White RS
    South Med J; 1989 Dec; 82(12):1483-6. PubMed ID: 2480649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S; Chandeying V
    J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Down's syndrome. Genetic counseling and prenatal diagnosis].
    Fuhrmann W
    Dtsch Med Wochenschr; 1979 Jul; 104(30):1055-8. PubMed ID: 157268
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
    Hsu JJ; Hsieh TT; Soong YK; Spencer K
    Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison between age-dependent (Wald alpha program) and age-independent (Ulm index) analysis program for prenatal detection of Down's syndrome with serum markers].
    Zwahr C; Voss P; Kistner G
    Z Geburtshilfe Neonatol; 1996; 200(5):181-5. PubMed ID: 9035827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum markers for Down's syndrome pregnancies.
    Chew S; Anandakumar C; Ratnam SS
    Singapore Med J; 1995 Aug; 36(4):417-23. PubMed ID: 8919160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making sense of maternal serum screening.
    Lindsay P
    Nurs Times; 1994 Dec 7-14; 90(49):30-2. PubMed ID: 7528377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal screening for open neural tube defects, Down's syndrome, and other major fetal disorders.
    Haddow JE
    Semin Perinatol; 1990 Dec; 14(6):488-503. PubMed ID: 1706536
    [No Abstract]   [Full Text] [Related]  

  • 15. Prenatal diagnosis.
    Ferguson-Smith MA
    Practitioner; 1974 Nov; 213(1277):655-66. PubMed ID: 4142084
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
    Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down syndrome: prenatal risk assessment and diagnosis.
    Newberger DS
    Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of Down syndrome: the Jerusalem experience.
    Bach G; Ben-Neriah Z; Sagi M
    Isr J Med Sci; 1993 Aug; 29(8):468-70. PubMed ID: 7691779
    [No Abstract]   [Full Text] [Related]  

  • 20. Down's syndrome risk estimates demonstrate considerable heterogeneity despite homogeneity of input.
    Reynolds T; Ellis A; Jones R
    Ann Clin Biochem; 2004 Nov; 41(Pt 6):464-8. PubMed ID: 15588435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.